Patent · US Revoked

Systems and methods for phototherapeutic modulation of nitric oxide

US11383095B2 · kind B2 · utility

0Cited by
159References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 10, 2019
Grant dateJul 12, 2022
Priority date
Expiry dateDec 10, 2039

Classification

  • Technology area (CPC —)General

Abstract

Systems and methods for phototherapeutic modulation of nitric oxide in mammalian tissue include use of a first wavelength and first radiant flux of light to stimulate enzymatic generation of nitric oxide, and use of a second wavelength and second radiant flux of light to stimulate release of nitric oxide from endogenous stores of nitric oxide. Pulsed light and/or partially non-overlapping light impingement windows may be used. Non-coherent light impinged on tissue may include a peak wavelength in a range of from 410 nm to 440 nm in the absence of light emissions having a peak wavelength of from 600 nm to 900 nm.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.